US68403P2039
US68403P2039
Oramed Pharmaceuticals Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.000.000 | -- | -- |
| Cost of Revenue | 1.987.000 | -- | -- |
| Gross Profit | 13.000 | -- | -- |
| 15.101.000 | 12.781.000 | 18.2% | |
| Operating Income | -15.088.000 | -12.781.000 | 18.1% |
| Pretax Income | 75.324.000 | -15.920.000 | 573.1% |
| Net Income Common Stockholders | 64.050.000 | -19.060.000 | 436.0% |
| -- | -- | -- | |
| -- | -- | -- |